AMERISAFE Zukünftiges Wachstum
Future Kriterienprüfungen 0/6
Der Gewinn von AMERISAFE wird voraussichtlich um 10.6% pro Jahr zurückgehen, während der Jahresumsatz um 4.6% pro Jahr wachsen soll. Der Gewinn je Aktie wird voraussichtlich um 10.9% pro Jahr sinken.
Wichtige Informationen
-10.6%
Wachstumsrate der Gewinne
-10.86%
EPS-Wachstumsrate
| Insurance Gewinnwachstum | 2.0% |
| Wachstumsrate der Einnahmen | 4.6% |
| Zukünftige Eigenkapitalrendite | n/a |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 27 Apr 2026 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Analyse-Update • Apr 28
AMSF: Higher Accident Year Losses And Margin Pressure Will Constrain Future Upside Potential
Analysts have trimmed AMERISAFE's price target to $31 from $36, citing updated assumptions for slower revenue growth, slightly lower profit margins, and a modestly reduced future P/E outlook after recent research following its Q4 earnings miss and higher accident year losses. Analyst Commentary Recent research updates highlight a more cautious tone around AMERISAFE, with several bearish analysts trimming price targets after the Q4 earnings miss and higher accident year losses.
Analyse-Update • Apr 14
AMSF: Premium Trends And Rebased P/E Are Expected To Drive Future Repricing
Analysts have reduced their price targets on AMERISAFE by about $11 to around $39. They cite recent earnings results in which higher accident year losses and revised growth and profitability assumptions are partially offset by higher premium growth and a recalibrated future P/E outlook.Analyse-Update • Mar 31
AMSF: Higher Accident Year Losses Will Limit Upside As Shares Appear Fairly Valued
Analysts have reset their price target on AMERISAFE to $36, a reduction of $9 from the prior $45 level, citing higher accident year losses partially offset by stronger premium growth and a view that the shares are now fairly valued. Analyst Commentary Bearish analysts are recalibrating expectations on AMERISAFE after the recent Q4 earnings miss, with a reset price target of $36 indicating a more cautious stance on the risk and reward tradeoff at current levels.Analyse-Update • Mar 16
AMSF: Higher Accident Year Losses Will Cap Upside Despite Ongoing Capital Returns
Analysts cut their price target on AMERISAFE to $36 from $45, citing recent Q4 earnings with higher accident year losses, partly offset by stronger premium growth, and a view that the shares now look fairly valued at this level. Analyst Commentary Bearish analysts are signaling a more cautious stance on AMERISAFE after the recent Q4 earnings miss, pointing to a mix of operational and valuation concerns that they believe limit upside at current levels.
Analyse-Update • Mar 02
AMSF: Premium Stability And Dividend Increases Will Support Future Share Returns
Narrative update on AMERISAFE The analyst price target for AMERISAFE has been revised from $60 to $50, reflecting analysts' lower external targets, including recent cuts from firms citing Q4 earnings pressure and higher accident year losses, partially balanced by premium growth. Analyst Commentary Recent research commentary on AMERISAFE has centered on the Q4 earnings miss and higher accident year losses, with analysts adjusting price targets to reflect a more cautious near term view on profitability.Analyse-Update • Feb 16
AMSF: Updated Revenue And P/E Assumptions Will Support Future Repricing Potential
Analysts have raised their fair value estimate for AMERISAFE from $47.67 to $50.00, reflecting updated assumptions on revenue growth, profit margins, the discount rate, and future P/E expectations. Analyst Commentary Bullish Takeaways Bullish analysts view the revised US$50.00 fair value estimate as consistent with their updated assumptions on revenue growth and profit margins, suggesting the business model still supports a premium to prior internal estimates.Analyse-Update • Feb 02
AMSF: Higher Fair Value Will Offset Margin Concerns And Support Multiple
Analysts have raised their fair value estimate for AMERISAFE to $45.00 from $43.00, citing updated views on revenue growth, profit margins, and future P/E assumptions following recent Street research, including the latest price target revision. Analyst Commentary Bearish analysts have taken a more cautious stance on AMERISAFE, reflected in at least one price target reduction that pulled the target down by $5.00.Analyse-Update • Jan 19
AMSF: Stable Earnings And Capital Returns Will Support Future Repricing
Analysts have trimmed their price targets on AMERISAFE by about $1.67 to reflect slightly lower fair value estimates and a modestly reduced future P/E assumption, while still expecting generally stable profitability. Analyst Commentary Recent research updates on AMERISAFE center on trimmed price targets and a valuation reset that analysts link to broader pressure across the property and casualty space, rather than to a major shift in the company’s underlying profitability outlook.Analyse-Update • Jan 05
AMSF: Lighter Catastrophe Activity And Book Value Trends Will Support Shares
Analysts have trimmed their fair value estimate for AMERISAFE to $60 from $65, tying the lower target to higher assumed discount rates, slightly softer profit margin expectations, and updated industry views on pricing and valuations in the P&C space. Analyst Commentary Recent research on AMERISAFE points to a more cautious stance on valuation across the P&C insurance space, even as expectations for generally stable profitability remain in place.Analyse-Update • Dec 14
AMSF: Sector Pressures Will Keep Multiple Constrained Despite Stable Profitability
Analysts have trimmed their price target on AMERISAFE to about $45 from roughly $50, reflecting pressure on broader P and C insurance valuations, even as they expect generally stable profitability and modest earnings tailwinds from a benign catastrophe loss environment. Analyst Commentary Bearish analysts see the latest price target cuts as a signal that AMERISAFE's valuation has less room for multiple expansion in the near term, even as fundamentals remain relatively stable.Analyseartikel • Dec 06
AMERISAFE, Inc.'s (NASDAQ:AMSF) Prospects Need A Boost To Lift Shares
AMERISAFE, Inc.'s ( NASDAQ:AMSF ) price-to-earnings (or "P/E") ratio of 14.1x might make it look like a buy right now...Analyse-Update • Nov 30
AMSF: Stable Profitability Will Persist Despite Sector Headwinds And CFO Transition
Analysts have revised AMERISAFE's price target downward, with the consensus fair value decreasing by about $1 to $49.33. They cite ongoing valuation pressures and a stable but modest financial outlook for the insurance sector.Analyse-Update • Nov 16
AMSF: Profitability Will Remain Resilient Despite Industry Valuation Headwinds
Analysts have lowered their average price target for AMERISAFE, citing industry-wide valuation pressures and expectations for stable profitability. Recent targets have been reduced by $5 to $20 compared to previous estimates.Analyse-Update • Nov 01
AMSF: Financial Tailwinds And Reduced Catastrophe Losses Will Support Share Performance
AMERISAFE's analyst price target has been revised downward by approximately $1.67 to $50.33. Analysts cite ongoing concerns about casualty loss reserves and a cautious pricing environment, despite modest financial tailwinds.Analyse-Update • Oct 16
Technology Investments Will Improve Underwriting Even As Pricing Pressures Mount
Analysts have lowered their price target for AMERISAFE from $54.33 to $52.00, citing a modestly improved profit margin. However, there is ongoing sector-wide caution regarding casualty loss reserves and pricing conditions.Analyseartikel • Mar 02
AMERISAFE (NASDAQ:AMSF) Is Due To Pay A Dividend Of $0.39
AMERISAFE, Inc. ( NASDAQ:AMSF ) will pay a dividend of $0.39 on the 21st of March. This makes the dividend yield 8.9...Seeking Alpha • Nov 20
Amerisafe Has A Premium Worth Paying
Summary Amerisafe's core profits have declined since 2019, but the company generates more profit per dollar invested, increasing its long-term corporate value. Specializing in workers' compensation insurance for hazardous industries, AMSF maintains high client satisfaction with a 94.1% policy renewal rate and a low expense ratio. Despite a drop in NOPAT, Amerisafe's ROIC has improved, indicating better balance sheet efficiency and potential for future profit growth. Trading at a modest premium, Amerisafe's rising ROIC justifies investment, with market expectations of NOPAT growth at no more than 17%. Read the full article on Seeking Alpha
Neue Analyse • Sep 24
Rising Premiums And Customer Loyalty Meet Analysts' Gloomy Earnings Forecast And Shrinking Margins
Enhanced agent engagement and strategic underwriting practices are improving profitability and financial stability.Analyseartikel • Aug 30
AMERISAFE's (NASDAQ:AMSF) Dividend Will Be $0.37
The board of AMERISAFE, Inc. ( NASDAQ:AMSF ) has announced that it will pay a dividend of $0.37 per share on the 20th...Analyseartikel • Apr 28
AMERISAFE (NASDAQ:AMSF) Has Announced A Dividend Of $0.37
AMERISAFE, Inc. ( NASDAQ:AMSF ) has announced that it will pay a dividend of $0.37 per share on the 21st of June. This...Analyseartikel • Feb 28
AMERISAFE (NASDAQ:AMSF) Is Due To Pay A Dividend Of $0.37
The board of AMERISAFE, Inc. ( NASDAQ:AMSF ) has announced that it will pay a dividend on the 22nd of March, with...Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2027 | 352 | 38 | N/A | N/A | 2 |
| 12/31/2026 | 333 | 38 | N/A | N/A | 2 |
| 3/31/2026 | 325 | 46 | 8 | 10 | N/A |
| 12/31/2025 | 317 | 47 | 9 | 11 | N/A |
| 9/30/2025 | 310 | 50 | 9 | 11 | N/A |
| 6/30/2025 | 306 | 50 | 8 | 9 | N/A |
| 3/31/2025 | 301 | 47 | 15 | 15 | N/A |
| 12/31/2024 | 309 | 55 | 23 | 24 | N/A |
| 9/30/2024 | 315 | 61 | 16 | 17 | N/A |
| 6/30/2024 | 309 | 57 | 13 | 14 | N/A |
| 3/31/2024 | 309 | 62 | 23 | 24 | N/A |
| 12/31/2023 | 307 | 62 | 29 | 30 | N/A |
| 9/30/2023 | 307 | 64 | 17 | 18 | N/A |
| 6/30/2023 | 305 | 65 | 23 | 24 | N/A |
| 3/31/2023 | 298 | 56 | 33 | 35 | N/A |
| 12/31/2022 | 295 | 56 | 26 | 28 | N/A |
| 9/30/2022 | 293 | 38 | 42 | 45 | N/A |
| 6/30/2022 | 295 | 46 | 35 | 37 | N/A |
| 3/31/2022 | 308 | 64 | 27 | 29 | N/A |
| 12/31/2021 | 316 | 66 | 37 | 38 | N/A |
| 9/30/2021 | 326 | 91 | 41 | 42 | N/A |
| 6/30/2021 | 336 | 95 | 46 | 47 | N/A |
| 3/31/2021 | 344 | 95 | 64 | 65 | N/A |
| 12/31/2020 | 340 | 87 | 62 | 63 | N/A |
| 9/30/2020 | 343 | 92 | 66 | 67 | N/A |
| 6/30/2020 | 352 | 90 | 80 | 81 | N/A |
| 3/31/2020 | 354 | 84 | 73 | 74 | N/A |
| 12/31/2019 | 370 | 93 | N/A | 79 | N/A |
| 9/30/2019 | 373 | 77 | N/A | 90 | N/A |
| 6/30/2019 | 375 | 76 | N/A | 101 | N/A |
| 3/31/2019 | 379 | 75 | N/A | 106 | N/A |
| 12/31/2018 | 378 | 72 | N/A | 98 | N/A |
| 9/30/2018 | 378 | 53 | N/A | 99 | N/A |
| 6/30/2018 | 377 | 50 | N/A | 127 | N/A |
| 3/31/2018 | 372 | 49 | N/A | 120 | N/A |
| 12/31/2017 | 375 | 46 | N/A | 131 | N/A |
| 9/30/2017 | 379 | 65 | N/A | 134 | N/A |
| 6/30/2017 | 384 | 66 | N/A | 99 | N/A |
| 3/31/2017 | 392 | 67 | N/A | 108 | N/A |
| 12/31/2016 | 397 | 78 | N/A | 114 | N/A |
| 9/30/2016 | 401 | 82 | N/A | 113 | N/A |
| 6/30/2016 | 400 | 82 | N/A | 123 | N/A |
| 3/31/2016 | 402 | 80 | N/A | 91 | N/A |
| 12/31/2015 | 402 | 70 | N/A | 93 | N/A |
| 9/30/2015 | 404 | 64 | N/A | 101 | N/A |
| 6/30/2015 | 409 | 60 | N/A | 107 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: AMSFFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-10.6% pro Jahr).
Ertrag vs. Markt: AMSFFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-10.6% pro Jahr).
Hohe Wachstumserträge: AMSFFür die nächsten 3 Jahre wird mit einem Rückgang der Erträge gerechnet.
Einnahmen vs. Markt: AMSFDie Einnahmen des Unternehmens (4.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (11.5% pro Jahr).
Hohe Wachstumseinnahmen: AMSFDie Einnahmen des Unternehmens (4.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von AMSF in 3 Jahren voraussichtlich hoch sein wird
Wachstumsunternehmen entdecken
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/07 20:42 |
| Aktienkurs zum Tagesende | 2026/05/07 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
AMERISAFE, Inc. wird von 10 Analysten beobachtet. 3 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Randy Binner | B. Riley Securities, Inc. |
| Matthew Carletti | Citizens JMP Securities, LLC |
| Meyer Shields | Keefe, Bruyette, & Woods |